Invesco’s OnKure Therapeutics OKUR Stock Holding History

Invesco’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44,936	Closed	-$3.42M	–	3906
2023 Q3	$3.42M	Buy	+44,936	New	+$3.06M	﹤0.01%	2391

Other funds holding OKUR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Invesco's OKUR Position: Q4 2023 in Review

Invesco sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 44,936 shares — an estimated $3.42M sold.

Invesco first reported a position in OKUR in Q3 2023 and held it in 1 quarter. The position peaked at $3.42M in Q3 2023. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

Invesco reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
Invesco sold 44,936 OnKure Therapeutics shares in Q4 2023, an estimated $3.42M.
Invesco first reported a position in OnKure Therapeutics in Q3 2023 and held it in 1 quarter.
Invesco's OnKure Therapeutics position peaked at $3.42M in Q3 2023.
68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.